Tencent co-led online health services provider Yuanxin Technology's series E round with fellow existing investor Sequoia Capital China.

Yuanxin Technology, the China-based developer of a telemedicine platform, has closed a RMB$3bn ($466m) series E round co-led by internet group Tencent, 36Kr reported today.

Venture capital firm Sequoia China co-led the round, which also featured VC firm Qiming Venture Partners, investment bank Citic Securities and CICC Capital, a subsidiary of investment banking firm China International Capital Corporation.

Founded in 2015, Yuanxin has created a mobile app called Miaoshou Doctor that enables users to access a network of 1.3 million…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.
Email LinkedIn